Digital PCR Assay Development

About Theradiag

Theradiag's mission is to advance personalized medicine through specialized diagnostic solutions for monitoring complex chronic diseases. The company has achieved a strong position in the European market for therapeutic drug monitoring of autoimmune diseases with its flagship Lisa-Tracker platform. Its strategy focuses on expanding its molecular diagnostics portfolio, forging strategic partnerships for commercial reach, and capitalizing on the growing demand for companion diagnostics in biotherapy management. As a publicly traded entity, Theradiag balances R&D investment with commercial execution to drive growth.

Therapeutic Areas

Other Oncology & Infectious Diseases Drugs